Thus, although PARG inhibition may be useful for treatment of certain cancers due to their complex etiology, the upregulation of PARG, which may be more straightforward and effective in other cancers, have not been thoroughly studied in vitro and in vivo. The gene discussed is PARG; the disease is cancer.